TipRanks
Aytu BioScience Inc (DE:AY20)
STUTTGART:AY20
Germany Market
AY20
Aytu BioScience
RESEARCH TOOLSreports

Aytu BioScience (AY20) Income Statement

0 Followers

Aytu BioScience Income Statement

Last quarter (Q4 2026), Aytu BioScience's total revenue was $16.11M, an increase of 6.42% from the same quarter last year. In Q4, Aytu BioScience's net income was $-15.00K. See Aytu BioScience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 26Jun 25Jun 24Jun 23Jun 22
Total Revenue
$ 57.57M$ 66.38M$ 65.18M$ 107.40M$ 96.67M
Gross Profit
$ 36.82M$ 45.83M$ 49.05M$ 66.63M$ 50.28M
Operating Expenses
$ 45.13M$ 53.66M$ 50.65M$ 83.70M$ 160.19M
Depreciation and Amortization
$ 3.93M$ 5.38M$ 6.72M$ 8.81M$ 10.15M
EBITDA
$ -4.38M$ -4.67M$ 1.41M$ -3.27M$ -27.96M
Operating Income
$ -8.31M$ -7.83M$ -1.59M$ -17.07M$ -109.91M
Other Income/Expenses
$ -5.92M$ -5.92M$ -8.79M$ 14.00K$ 1.02M
Pretax Income
$ -14.23M$ -13.74M$ -10.38M$ -17.05M$ -108.89M
Net Income
$ -14.25M$ -13.56M$ -15.84M$ -17.05M$ -108.78M
Per Share Metrics
Basic EPS
$ -1.16$ -2.16$ -2.86$ -5.11$ -74.01
Diluted EPS
$ -1.16$ -2.16$ -2.86$ -5.11$ -74.01
Weighted Average Shares Outstanding
 12.32M 6.28M 5.54M 3.34M 1.47M
Weighted Average Shares Outstanding (Diluted)
 12.32M 6.28M 5.54M 3.34M 1.47M
Currency in USD

Aytu BioScience Earnings and Revenue History